Comparison of the effects of propofol and desflurane on lung collapse and operative time during VATS lobectomy

Comparison of the effects of propofol and desflurane on lung collapse and operative time during VATS lobectomy - Comparison of the effects of propofol and desflurane on lung collapse and operative time during VATS lobectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009412

Enrollment

Registered

2012-11-27

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

To use 4-6 % of desflurane in maintenance of anesthesia of thoracic surgery during VATS lobectomy anesthesia To use 2-4 mcg/ml of propofol in maintenance of anesthesia of thoracic surgery during VAT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who are indicated to VATS lobectomy, and age 20-65 years, American Society of Anesthesiologists physical status class 1-2, Hugh-Jones class 1-2, and New York Heart Association class 1-2

Exclusion criteria

Exclusion criteria: history of cardiovascular or cerebrovascular disease and anticoagulant medication, severe chronic obstructive pulmonary disease, defined as %FEV1.0 < 50% of the predicted values; or severe restrictive lung disease, defined as %VC < 50% of the predicted values

Design outcomes

Primary

Measure	Time frame
lung collapse score duration of surgery	—

Secondary

Measure	Time frame
postoperative complication life prognosis	—

Countries

Japan

Contacts

Public ContactRyosuke Kawanishi

Tokushima University Department of Anesthesiology

Kawanishi.riyosuke@tokushima-u.ac.jp0886337181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026